APPLICATIONS
RELIABLE - ADAPTABLE - SCALABLE
BIOMANUFACTURING BIOLOGICS FOR A BRIGHTER FUTURE
We are developing a novel platform for the manufacture and delivery of biologics for a range of applications.
HUMAN VACCINES
Biological production needle-free vaccines utilizing the latest in vaccine design, such as virus-like particle or mRNA vaccines, which are self-formulating and self-encapsulating for oral or nasal delivery.
MONOCLONAL ANTIBODIES
Produce monoclonal antibodies through a reliable and economic bioengineering platform.
GENE THERAPIES
Bioengineering & biomanufacturing nucleic acid delivery solutions for a range of diseases. These can be self-encapsulating and delivered orally, nasally or intramuscularly.
ANIMAL HEALTHCARE
Produce modern and affordable vaccines for livestock, aquaculture and companion animals, such as virus-like particle or mRNA vaccines, which are self-formulating and self-encapsulating for needle-free delivery.
DELIVERY
Our food grade cyanobacteria platform allows for the delivery of biologics for these applications either orally, nasally, intramuscularly, or subcutaneously.
THERAPEUTIC COMPOUNDS
The flexibility of our cyanobacteria engineering platform allows us to biologically produce a range of therapeutic compounds that independently, or in combination with our other modalities, improve health, and treatment efficacy.
ASTAXANTHIN
We biomanufacture high quality astaxanthin, stereochemically identical to that produced by Haematococcus pluvialis, using less land, water and energy whilst capturing and utilizing CO2. Astaxanthin has been shown to be a highly effective anti-oxidant with promising therapeutic properties.
Our astaxanthin is identical to that produced by Haematococcus pluvialis and, thanks to our advanced bioengineering Cyanoworks™ technology, can be biomanufactured more cost-effectively and sustainably. Our process consumes less land, water and energy so that these precious resources are available to help feed the planet.